highly significantP < 0.001
The median progression-free survival (PFS) for patients classified as responders by DECT reached 623 days, compared with a mere 104 days for nonresponders, representing a highly significant difference ( P < 0.001).
The median progression-free survival (PFS) for patients classified as responders by DECT reached 623 days, compared with a mere 104 days for nonresponders, representing a highly significant difference ( P < 0.001).